Subcutaneous integrin inhibitors may provide more treatment options for patients with moderate-to-severe ulcerative colitis

被引：1

作者：

Yoon, Hyuk ^{[1
]}

机构：

[1] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, 82 Gumi Ro 173Beon Gil, Seongnam 13620, South Korea

来源：

INTESTINAL RESEARCH | 2019年 / 17卷 / 03期

关键词：

INFLAMMATORY-BOWEL-DISEASE; MONOCLONAL-ANTIBODY; VEDOLIZUMAB; INDUCTION; THERAPY;

D O I：

10.5217/ir.2019.00070

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：283 / 284

页数：2

共 9 条

[1]

[Anonymous], UNITED EUROPEAN G S1

[2] Vedolizumab induction therapy for inflammatory bowel disease in clinical practice - a nationwide consecutive German cohort study [J].

Baumgart, D. C. ;

Bokemeyer, B. ;

Drabik, A. ;

Stallmach, A. ;

Schreiber, S. .

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2016, 43 (10) :1090-1102

[3] Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis [J].

Feagan, Brian G. ;

Rutgeerts, Paul ;

Sands, Bruce E. ;

Hanauer, Stephen ;

Colombel, Jean-Frederic ;

Sandborn, William J. ;

Van Assche, Gert ;

Axler, Jeffrey ;

Kim, Hyo-Jong ;

Danese, Silvio ;

Fox, Irving ;

Milch, Catherine ;

Sankoh, Serap ;

Wyant, Tim ;

Xu, Jing ;

Parikh, Asit .

NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (08) :699-710

[4]

Hibi T, 2019, INTEST RES, V17, P375

[5] Long-term Efficacy of Vedolizumab for Ulcerative Colitis [J].

Loftus, Edward V., Jr. ;

Colombel, Jean-Frederic ;

Feagan, Brian G. ;

Vermeire, Severine ;

Sandborn, William J. ;

Sands, Bruce E. ;

Danese, Silvio ;

D'Haens, Geert R. ;

Kaser, Arthur ;

Panaccione, Remo ;

Rubin, David T. ;

Shafran, Ira ;

McAuliffe, Megan ;

Kaviya, Arpeat ;

Sankoh, Serap ;

Mody, Reema ;

Abhyankar, Brihad ;

Smyth, Michael .

JOURNAL OF CROHNS & COLITIS, 2017, 11 (04) :400-411

[6] Clinical pharmacology of AMG 181, a gut-specific human anti-α4β7 monoclonal antibody, for treating inflammatory bowel diseases [J].

Pan, Wei-Jian ;

Koeck, Kathleen ;

Rees, William A. ;

Sullivan, Barbara A. ;

Evangelista, Christine M. ;

Yen, Mark ;

Andrews, Jane M. ;

Radford-Smith, Graham L. ;

Prince, Peter J. ;

Reynhardt, Kaz O. ;

Doherty, David R. ;

Patel, Sonal K. ;

Krill, Christine D. ;

Zhou, Kefei ;

Shen, Jing ;

Smith, Lynn E. ;

Gow, Jason M. ;

Lee, Jonathan ;

Treacy, Anthony M. ;

Yu, Zhigang ;

Platt, Virginia M. ;

Borie, Dominic C. .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 78 (06) :1315-1333

[7] Cell Trafficking Interference in Inflammatory Bowel Disease: Therapeutic Interventions Based on Basic Pathogenesis Concepts [J].

Perez-Jeldres, Tamara ;

Tyler, Christopher J. ;

Boyer, Joshua D. ;

Karuppuchamy, Thangaraj ;

Bamias, Giorgos ;

Dulai, Parambir S. ;

Boland, Brigid S. ;

Sandborn, William J. ;

Patel, Derek R. ;

Rivera-Nieves, Jesus .

INFLAMMATORY BOWEL DISEASES, 2019, 25 (02) :270-282

[8] Efficacy and Safety of Abrilumab in a Randomized, Placebo-Controlled Trial for Moderate-to-Severe Ulcerative Colitis [J].

Sandborn, William J. ;

Cyrille, Marcoli ;

Hansen, Mark Berner ;

Feagan, Brian G. ;

Loftus, Edward V., Jr. ;

Rogler, Gerhard ;

Vermeire, Severine ;

Cruz, Martha L. ;

Yang, Jun ;

Boedigheimer, Michael J. ;

Abuqayyas, Lubna ;

Evangelista, Christine M. ;

Sullivan, Barbara A. ;

Reinisch, Walter .

GASTROENTEROLOGY, 2019, 156 (04) :946-+

[9] An Overview of the Mechanism of Action of the Monoclonal Antibody Vedolizumab [J].

Wyant, Tim ;

Fedyk, Eric ;

Abhyankar, Brihad .

JOURNAL OF CROHNS & COLITIS, 2016, 10 (12) :1437-1444

← 1 →